Cleared Special

K192116 - Human IgA liquid reagent kit for Use on SPAPlus (FDA 510(k) Clearance)

Sep 2019
Decision
29d
Days
Class 2
Risk

K192116 is an FDA 510(k) clearance for the Human IgA liquid reagent kit for Use on SPAPlus. This device is classified as a Method, Nephelometric, Immunoglobulins (g, A, M) (Class II - Special Controls, product code CFN).

Submitted by The Binding Site Group , Ltd. (Birmingham, GB). The FDA issued a Cleared decision on September 4, 2019, 29 days after receiving the submission on August 6, 2019.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5510.

Submission Details

510(k) Number K192116 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 2019
Decision Date September 04, 2019
Days to Decision 29 days
Submission Type Special
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code CFN — Method, Nephelometric, Immunoglobulins (g, A, M)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5510